Steven A. Shallcross - CEO and CFO, Director at Theriva Biologics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and CFO, Director
Stock Symbol
TOVX on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Steven A. Shallcross since 11/4/2023

Holdings reported by Steven A. Shallcross for Theriva Biologics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 250K $173K $0.69 Jun 7, 2023 Direct
Stock Options (right to buy) 700K Dec 14, 2023 Direct Common Stock

Transactions reported by Steven A. Shallcross for Theriva Biologics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.